loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about MolPort-001-011-909, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    MolPort-001-011-909

    APIs // Active Pharmaceutical Ingredients

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 127464-43-1, 2-ethyl-6-methylpyridin-3-ol succinate, Emoxypine succinate, 2-ethyl-3-hydroxy-6-methylpyridine succinate, Emoxypine (succinate), Butanedioic acid, compd. with 2-ethyl-6-methyl-3-pyridinol (1:1)
    Molecular Formula
    C12H17NO5
    Molecular Weight
    255.27  g/mol
    InChI Key
    IKMNOGHPKNFPTK-UHFFFAOYSA-N
    FDA UNII
    2R985002CT
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    butanedioic acid;2-ethyl-6-methylpyridin-3-ol
    2.1.2 InChI
    InChI=1S/C8H11NO.C4H6O4/c1-3-7-8(10)5-4-6(2)9-7;5-3(6)1-2-4(7)8/h4-5,10H,3H2,1-2H3;1-2H2,(H,5,6)(H,7,8)
    2.1.3 InChI Key
    IKMNOGHPKNFPTK-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCC1=C(C=CC(=N1)C)O.C(CC(=O)O)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    2R985002CT
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-ethyl-6-methyl-3-hydroxypyridine Succinate

    2. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)

    3. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)

    4. Emoxypine Succinate

    5. Methylethylpiridinol Succinate

    6. Mexiprim

    2.3.2 Depositor-Supplied Synonyms

    1. 127464-43-1

    2. 2-ethyl-6-methylpyridin-3-ol Succinate

    3. Emoxypine Succinate

    4. 2-ethyl-3-hydroxy-6-methylpyridine Succinate

    5. Emoxypine (succinate)

    6. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)

    7. 2r985002ct

    8. 2-ethyl-6-methyl-3-pyridinol Succinate (salt)

    9. Mexiprim

    10. Emicidine

    11. 2-ethyl-6-methyl-3-hydroxypyridine Succinate

    12. Methylethylpiridinol Succinate

    13. 2-ethyl-6-methyl-3-pyridinol Succinate

    14. Unii-2r985002ct

    15. Emicidin

    16. Mexicor

    17. Cambridge Id 5110148

    18. Schembl1010987

    19. Dtxsid30155577

    20. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)

    21. Bcp13396

    22. Hy-w002620a

    23. Mfcd00445612

    24. Akos003239209

    25. 2-ethyl-6-methylpyridin-3-olsuccinate

    26. Ds-13730

    27. Cs-0182823

    28. E1069

    29. Ft-0660570

    30. Butanedioic Acid;2-ethyl-6-methylpyridin-3-ol

    31. Methylethylpiridinol Succinate [who-dd]

    32. T71674

    33. 647m960

    34. A805706

    35. Q-100116

    36. Q27255507

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 255.27 g/mol
    Molecular Formula C12H17NO5
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count4
    Exact Mass255.11067264 g/mol
    Monoisotopic Mass255.11067264 g/mol
    Topological Polar Surface Area108 Ų
    Heavy Atom Count18
    Formal Charge0
    Complexity198
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Psychotropic Drugs

    A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)

    Platelet Aggregation Inhibitors

    Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

    Antioxidants

    Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)

    Post Enquiry
    POST ENQUIRY